MOSCOW (MRC) -- Evonik Industries, a leading specialty chemicals manufacturer,and the University of Tokyo plan to work together closely in selected fields in the future and have sealed a strategic partnership for this purpose, according to the company's press release.
The University of Tokyo, one of the most important universities in the world, is now Evonik’s fourth strategic university partner. Such partnerships already exist with the University of Minnesota in the USA, the renowned Shanghai Jiao Tong University (SJTU) in China, and with King Abdullah University of Science and Technology (KAUST) in Saudi Arabia.
Additionally, in the fall of 2013, Evonik signed a memorandum of understanding regarding a strategic partnership with the Agency for Science, Technology, and Research, the leading major national research institution in Singapore. "These partnerships are an important tool for our international innovation strategy," stated Senior representative of the Evonik Group in Japan. "Networking worldwide with top institutions gives us access to scientific excellence and researchers with outstanding educational backgrounds."
Strategic partnerships with universities in all important regions of the world create a framework for Evonik for joint research projects and a regular sharing of research trends in science and industry.
As MRC informed earlier, Evonik Industries is paving the way for a new technology whose applications include automotive finishes that are more scratch-resistant than ever before. The specialty chemicals company has developed an industrial-scale method for producing silane-modified binders for automotive finishes.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around EUR12.9 billion and an operating profit (adjusted EBITDA) of about EUR2.0 billion.
MRC